4D Molecular Therapeutics, Inc. (FDMT) Revenue 2019–2025
4D Molecular Therapeutics, Inc. (FDMT) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$85.2MFY2025 · since FY2019: $7.0M → $85.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $85.2M | +230194.6% |
| FY2024 | $37,000 | -99.8% |
| FY2023 | $20.7M | +562.3% |
| FY2022 | $3.1M | -82.7% |
| FY2021 | $18.0M | +35.0% |
| FY2020 | $13.4M | +92.0% |
| FY2019 | $7.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice